Full name
PHARMACO GROUP SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
PHARMACO GROUP SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. DOMANIEWSKA 47 / 10, 02-672 WARSZAWA
TAX ID7123319777
Rate company:
PHARMACO GROUP SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID7123319777
KRS0000639395
Share capital572,000.00 zł
address
UL. DOMANIEWSKA 47 / 10, 02-672 WARSZAWA
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
7123319777
REGON
365509198
KRS
0000639395
Legal form
limited liability company
Register Address
UL. DOMANIEWSKA 47 / 10, 02-672 WARSZAWA
Date of registration in KRS
2016-09-29
Date of commencement of economic activity
2016-09-29
Act signature
RDF/661882/24/268
Pkd codes
21.20.Z - Manufacture of medicines and other pharmaceutical products
68.20.Z - Rental and operating of own or leased real estate
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Profit (loss) on sale  | ||||
Gross profit (loss) | 163,5 | 121,2 | 134,3 | 10,8 |
EBITDA | 192,7 | 135,4 | 148,7 | 9,9 |
Short time liabilities | 15,5 | 18,1 | 19,3 | 6,9 |
Other operating costs | ||||
Equity capital | 710,5 | 681,8 | 804 | 17,9 |
Operating profit (EBIT) | 163,7 | 121,2 | 134,5 | 11 |
Assets | 725,9 | 699,9 | 823,3 | 17,6 |
Net profit (loss) | 146,4 | 109,8 | 122,2 | 11,3 |
Cash | 188,1 | 143,2 | 49,2 | -65,7 |
Net income from sale | 174 | 174 | 174 | 0 |
Liabilities and provisions for liabilities | 15,5 | 18,1 | 19,3 | 6,9 |
Working assets | 209,7 | 197,9 | 335,5 | 69,5 |
Other income costs | ||||
Depreciation | 29 | 14,2 | 14,2 | 0 |
% | % | % | p.p. | |
Profitability of capital | 20,6 | 16,1 | 15,2 | -0,9 |
Equity capital to total assets | 97,9 | 97,4 | 97,7 | 0,3 |
Gross profit margin | 94 | 69,6 | 77,2 | 7,6 |
EBITDA Margin | 110,7 | 77,8 | 85,5 | 7,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 32 | 38 | 41 | 3 |
Current financial liquidity indicator | 13.555322647094727 | 10.948013305664062 | 17.35877227783203 | 6,5 |
Net dept to EBITDA | -0.9759418964385986 | -1.0578486919403076 | -0.33074042201042175 | 0,8 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Activity report
Download xmlShow more (2)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
Wamed-Lab sp. z o.o.
Warszawa
CMS Polska sp. z o.o.
Rzeszów
ZIELARNIA ANNA RADOŃ
Bełchatów
APTEKA ŚW. TOMASZA G. STOWSKA
Katowice
Red Med Poland Sp. z o.o.
Chorzów